Harvard Medical School

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Defending pharma tax breaks for ads will be challenging, lobbyist says

Health By Melissa Bailey

Harvard Medical School eases rule on faculty ties to industry

Dr. Kristen Goodell Harvard Medical School

Health By Melissa Bailey

Harvard has one of the best medical schools. Why does it ignore family medicine?

Science Happens! By Carl Zimmer

Watch: Episode 4: Can a worm’s lifespan hold the secrets to human aging?

Health By Jennifer Adaeze Okwerekwu

Medical students demand an end to pricey exam testing patient care skills

Health By Melissa Bailey

Recruited to lead Harvard Med, ‘fearless’ scientist chose Dana-Farber

Health By Melissa Bailey

Harvard Medical School students decry lack of diversity

Health By Melissa Bailey

Could Harvard Medical School sell its naming rights for $1 billion?

Health By Melissa Bailey

Harvard Med narrows faculty gender gap, but slowly

In the Lab By Andrew Joseph and Sharon Begley

God, malaria, and wolverine claws: Colbert talks CRISPR with George Church

Health By Melissa Bailey

3 people to watch in Longwood in 2016

Business By Rebecca Robbins

Inside the decade-long push to turn a Harvard discovery into a blockbuster medicine

Health By Melissa Bailey

How a former ‘street kid’ scooped up NIH grants and shook up medical research

In the Lab By Charles Piller

Google’s next big idea: Mining health data to prevent disease

Health By Melissa Bailey

Harvard Medical School eases up on contentious ethics rule

Health By Melissa Bailey

No longer invisible: The faces of rare disease

Health By Melissa Bailey

Most Read

Two dozen states side with HHS in its raucous dispute with pharma over a drug discount program

Google taps FDA’s former digital health chief for global strategy role

FDA rejects antidepressant seen as possible Covid-19 treatment

Apollo acquires minority stake in Sofinnova, extending private equity dealmaking in life sciences

The need for speed and safety: A primer on the FDA’s drug approval pathways

Greece plans to go to court to seek compensation from Novartis over a bribery scandal

Pharmalittle: FDA OKs new type of diabetes drug from Lilly; Early-stage biotechs are juicy targets for M&A surge

Seagen CEO resigns after arrest on domestic assault charges

All Coverage

Pharmalot, Pharmalittle: Defending pharma tax breaks for ads will be challenging, lobbyist says

Harvard Medical School eases rule on faculty ties to industry

Harvard has one of the best medical schools. Why does it ignore family medicine?

Watch: Episode 4: Can a worm’s lifespan hold the secrets to human aging?

Medical students demand an end to pricey exam testing patient care skills

Recruited to lead Harvard Med, ‘fearless’ scientist chose Dana-Farber

Harvard Medical School students decry lack of diversity

Could Harvard Medical School sell its naming rights for $1 billion?

Harvard Med narrows faculty gender gap, but slowly

God, malaria, and wolverine claws: Colbert talks CRISPR with George Church

3 people to watch in Longwood in 2016

Inside the decade-long push to turn a Harvard discovery into a blockbuster medicine

How a former ‘street kid’ scooped up NIH grants and shook up medical research

Google’s next big idea: Mining health data to prevent disease

Harvard Medical School eases up on contentious ethics rule

No longer invisible: The faces of rare disease

Exclusive: Harvard Medical School dean will step down